RH
Roger
Highfield
Roger Highfield: 80 per cent executive at the Science Museum Group / 20 per cent author, journalist and broadcaster. Views expressed here are 100 per cent his own.
twitter
Dinosaur-dooming asteroid struck earth at 'deadliest possible' angle https://t.co/6bvMjAXoYs
articles
Here are a few of my latest articles. There are more in my archive.
25
May
CORONAVIRUS: HOW THE VIRUS WORKS
The development of COVID-19 treatments, tests, drugs and vaccines will be accelerated by molecular understanding of the COVID-19 virus
Read more
18
May
coronavirus; from r to lifting lockdowns
Roger Highfield on why the fate of the nation rests on R, the ‘reproduction number’, and a novel ‘stringency index’ that compares the pandemic responses of 160 nations.
Read more
11
May
coronavirus: digital detectives
Roger Highfield discusses how digital technologies can curb COVID19 and why South Korea’s death toll is relatively low.
Read more
04
May
Quest for a Covid19 cure
In his latest Science Museum blog, Roger Highfield describes the first glimmer of hope for a COVID19 treatment
Read more
04
May
going viral
Roger Highfield, in conversation withAjit Lalvani. Imperial College London's Chair of Infectious Diseases, for the Jaipur Literature Festival
Read more
27
Apr
Hunting down COVID19
Roger Highfield talks to Kari Stefansson, whose genetic sequencing project has revealed how the UK infected Iceland, that children don’t seem to infect parents, and how to control COVID-19
Read more
21
Apr
Coronavirus: exit strategies
Roger Highfield, Science Director, outlines the science of lockdowns and how to end the pandemic.
Read more
20
Apr
Science of Coronavirus (in German)
Ulrike Kastrup of the ETH has translated my @sciencemuseum #COVID19 blogs from English into German:
Read more
13
Apr
Up close with the Coronavirus enemy
Roger Highfield, Science Director, talks to Ajit Lalvani, who recently recovered from a serious COVID-19 infection and is now undertaking a major pandemic study
Read more
06
Apr
Coronavirus Science: Ending the Pandemic
Roger Highfield summarizes the global race to develop an effective vaccine
Read more